Helping people with HIV quit tobacco in Kenya
Official title: Integrating tobacco use cessation into HIV Care and Treatment in Ministry of Health Facilities in Kisumu County, Kenya
Funded at University of California, San Francisco · NIH-10909243 · Data updated 2026-11-12
This study is testing a new way to help people living with HIV in Kenya quit smoking by adding support programs right into their regular HIV care, making it easier for them to stop using tobacco and improve their health.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 16, 2021 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $719,121 |
| NIH project number | 5U01CA261620-04 |
| Project ID | NIH-10909243 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals aged 21 and older living with HIV who also use tobacco.
✕Less likely to help
Patients who do not use tobacco or are under 21 years old may not receive any benefit from this research.
What this research studies
This research focuses on integrating tobacco cessation programs into HIV care for individuals living with HIV in Kenya. It aims to address the high rates of tobacco use among this population, which is linked to increased mortality and health complications. By implementing the National Guidelines for Tobacco Dependence Treatment and Cessation in HIV clinics, the project seeks to provide support for quitting tobacco in a primary care setting. The approach involves collaboration with local health services to ensure effective delivery of cessation interventions.
Why it matters
Potential benefit: If successful, this research could significantly improve the health outcomes of people living with HIV by reducing tobacco-related illnesses and mortality.
How similar studies have gone: While there is limited research on integrating tobacco cessation in HIV care in Kenya, similar approaches in other regions have shown promise in improving health outcomes for people living with HIV.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Bialous, Stella Aguinaga — University of California, San Francisco
- Study coordinator: Bialous, Stella Aguinaga
Related research
Other NIH-funded projects on the same topics.
-
Phone text program to help people with HIV in Uganda and Zambia stop smoking
This program uses tailored text messages and nicotine patches to help people living with HIV in Uganda and Zambia quit tobacco.
-
Tobacco quitting support for people living with HIV in Kisumu County, Kenya
This project brings tobacco‑cessation help into HIV clinics so people living with HIV in Kisumu can get counseling and support to quit tobacco.
-
Helping people living with HIV in Uganda and Zambia quit smoking using phone-based support.
This study is testing a helpful phone program that sends supportive text messages to people living with HIV in Uganda and Zambia to help them quit smoking, comparing it to regular care like advice and nicotine patches.
-
Ending Tobacco Use with a Smartphone Program for Cambodian People Living with HIV/AIDS
A smartphone-based quit-smoking program designed for people living with HIV/AIDS in Cambodia to help reduce tobacco use alongside HIV treatment.
-
Optimizing lung cancer care with smart tools for prevention, early detection, treatment, and survivorship
A U01 grant using AI and biomarkers to improve lung cancer prevention, screening, treatment, and survivorship care for people at risk or living with lung cancer.
-
How deforestation affects alcohol and tobacco use in Indonesia
This project looks at whether forest loss in Indonesia is linked to changes in people's tobacco and alcohol use across different places and years.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.